Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603102's EV-to-FCF is ranked better than 68.85% of 1191
companies
in the Consumer Packaged Goods industry
Industry Median: 15.91
vs SHSE:603102: 9.97
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Weihai Baihe Biology Technological Co (SHSE:603102) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Weihai Baihe Biology Technological Co's PE Ratio (TTM) for today is calculated as:
Weihai Baihe Biology Technological Co's share price for today is ¥31.68.
Weihai Baihe Biology Technological Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.960.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Weihai Baihe Biology Technological Co EV-to-FCF Related Terms
Weihai Baihe Biology Technological Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Weihai Baihe Biology Technological Co EV-to-FCF Chart
For the Packaged Foods subindustry, Weihai Baihe Biology Technological Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Weihai Baihe Biology Technological Co EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Weihai Baihe Biology Technological Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Weihai Baihe Biology Technological Co's EV-to-FCF falls into.
Weihai Baihe Biology Technological Co's current Enterprise Value is ¥984.2 Mil.
Weihai Baihe Biology Technological Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥98.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Weihai Baihe Biology Technological Co (SHSE:603102) has a EV-to-FCF of 9.97 as of Jul. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Weihai Baihe Biology Technological Co and its competitors. This is 38% below median its historical median of 16.03. Over the past decade, Weihai Baihe Biology Technological Co's EV-to-FCF has ranged from 7.98 to 102.58. According to the industry distribution chart, Weihai Baihe Biology Technological Co ranks #371 out of 1191 companies in the Consumer Packaged Goods industry, placing it in the top 31.2%.
Is Weihai Baihe Biology Technological Co's EV-to-FCF too high?
Weihai Baihe Biology Technological Co's current EV-to-FCF of 9.97 is 38% below median its 10-year median of 16.03. Over the past 10 years, this metric has ranged from a low of 7.98 to a high of 102.58. The Consumer Packaged Goods industry median EV-to-FCF is 15.91. Weihai Baihe Biology Technological Co's value of 9.97 is 37.3% below this industry median. Based on the distribution chart, Weihai Baihe Biology Technological Co ranks #371 out of 1191 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Weihai Baihe Biology Technological Co has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Weihai Baihe Biology Technological Co's EV-to-FCF compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Weihai Baihe Biology Technological Co ranks #371 out of 1191 companies for EV-to-FCF. This puts Weihai Baihe Biology Technological Co in the upper half of its industry. The industry median EV-to-FCF is 15.91. Weihai Baihe Biology Technological Co's value of 9.97 is 37.3% below this benchmark. Historically, Weihai Baihe Biology Technological Co's own EV-to-FCF has ranged from 7.98 to 102.58 over the past decade. While the company's 10-year median is 16.03 vs. the industry median of 15.91, Weihai Baihe Biology Technological Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 15.91, based on 1,191 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Weihai Baihe Biology Technological Co's current EV-to-FCF of 9.97 is 37.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Weihai Baihe Biology Technological Co and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 15.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Weihai Baihe Biology Technological Co's current EV-to-FCF is 9.97, which is 38% below median its own 10-year median of 16.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Weihai Baihe Biology Technological Co stock overvalued right now?
Based on GuruFocus' analysis, Weihai Baihe Biology Technological Co (SHSE:603102) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥48.82, compared to a current price of ¥31.68 — trading 35.1% below its estimated fair value. The current EV-to-FCF is 9.97, which is 38% below median its 10-year median of 16.03 and 37.3% below the Consumer Packaged Goods industry median of 15.91. Weihai Baihe Biology Technological Co's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Weihai Baihe Biology Technological Co (SHSE:603102), the current EV-to-FCF is 9.97 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Weihai Baihe Biology Technological Co (SHSE:603102) Overvalued in 2026?
Based on GuruFocus' analysis, Weihai Baihe Biology Technological Co stock appears to be undervalued.
The current stock price of ¥31.68 is trading 35.1% below its estimated GF Value™ of ¥48.82.
GuruFocus considers Weihai Baihe Biology Technological Co to be Significantly Undervalued.
Key valuation signals for SHSE:603102:
EV-to-FCF: 9.97 (38% below median its 10-year median of 16.03)
GF Value™: ¥48.82 vs. price of ¥31.68 (35.1% below fair value)
Industry Position: 37.3% below the Consumer Packaged Goods median (#371 of 1191)
No single metric tells the full story. See the SHSE:603102 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Weihai Baihe Biology Technological Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603102 has been successfully added to your 
